CRBP
NASDAQ · Biotechnology
Corbus Pharmaceuticals Holdi
$6.13
-0.21 (-3.31%)
Open$6.59
Previous Close$6.34
Day High$6.68
Day Low$6.06
52W High$20.56
52W Low$6.25
Volume—
Avg Volume739.3K
Market Cap118.95M
P/E Ratio—
EPS$-6.17
SectorBiotechnology
Analyst Ratings
Strong Buy
16 analysts
Price Target
+98.2% upside
Current
$6.13
$6.13
Target
$12.15
$12.15
$8.71
$12.15 avg
$17.60
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 72.40M | 73.75M | 70.02M |
| Net Income | -2,537,554 | -2,715,843 | -3,439,667 |
| Profit Margin | -3.5% | -3.7% | -4.9% |
| EBITDA | -3,891,696 | -4,515,140 | -4,413,459 |
| Free Cash Flow | -4,239,895 | -2,837,667 | -3,192,005 |
| Rev Growth | +4.2% | -7.8% | -7.0% |
| Debt/Equity | 0.37 | 0.31 | 0.36 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $262.82 | +1.11% | 72.8 | 459.33B |
| AMGN | Amgen Inc | $403.04 | -1.04% | 25.1 | 219.33B |
| GILD | Gilead Sciences Inc | $144.74 | -1.87% | — | 179.15B |
| VRTX | Vertex Pharmaceuticals Inc | $504.73 | -0.40% | 30.1 | 132.51B |
| REGN | Regeneron Pharmaceuticals | $735.20 | +0.05% | 17.4 | 75.36B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.72 | -4.96% | 36.9 | 29.82B |